Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00795288 · ClinicalTrials.gov registry record · Phase 1
Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH)
A Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 42
- Enrollment target
NCT00795288: Completed Phase 1 study, sponsored by Washington University School of Medicine.
NCT00795288 is a Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 42 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (30% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00795288, a Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 42 participants
- Enrollment target
Study Summary
The primary objective of this project is to investigate the effect of statin therapy on cerebral blood flow in patients with aneurysmal SAH who are randomized to receive or not receive statins in a blinded design.
Primary Outcome
Resting cerebral blood flow during peak period of vasospasm risk measured by PET
Interventions
- DRUG placebo
- DRUG Simvastatin, 80 mg/day for 21 days
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2008-08 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
What the finished NCT00795288 record still lists
NCT00795288 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (30% lower).
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00795288 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00795288 about?
NCT00795288 is a clinical study titled "Statins and Cerebral Blood Flow in Subarachnoid Hemorrhage (SAH)". The primary objective of this project is to investigate the effect of statin therapy on cerebral blood flow in patients with aneurysmal SAH who are randomized to receive or not receive statins in a blinded design.
What is the current status of trial NCT00795288?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2008-08. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00795288?
The interventions under investigation include: placebo (DRUG), Simvastatin, 80 mg/day for 21 days (DRUG).
Who is sponsoring clinical trial NCT00795288?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00795288's enrollment target sits among peer trials
42 1105th of 2000 higher than 876 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02852213 · 42 participants · Phase 1
A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
- NCT03136146 · 42 participants · Phase 2
Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia
- NCT03178149 · 42 participants · Phase 1
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
- NCT03663530 · 42 participants · NA
Circadian Misalignment and Energy Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia